Effect of bromocriptine in the treatment of rheumatoid arthritis patients
Not Applicable
- Conditions
- Rheumatoid Arthritis.Rheumatoid arthritis, unspecified
- Registration Number
- IRCT201109187577N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 174
Inclusion Criteria
patients with rheumatoid arthritis by American College of Rheumatology criteria (ACR)
Exclusion criteria: Patients who do not regularly take their medications
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of joint pain. Timepoint: Before the intervention, and at 1, 2, 4 and 6 months. Method of measurement: Visual analog scale (VAS.;Number of swollen joints. Timepoint: before the start intervention and end of 1, 2, 4 and 6 months after intervention. Method of measurement: Examination.;The number of painful joints. Timepoint: Before the intervention, and at months 1, 2, 4 and 6 after. Method of measurement: The patient's history.
- Secondary Outcome Measures
Name Time Method ESR. Timepoint: Before the intervention and after 1, 2, 4 and 6 months. Method of measurement: lab test.